Skip to main content

Pharmacy

By Jeff Lagasse | 09:23 am | September 19, 2023
The agency says current data does not support the recommended dosage of phenylephrine as an effective decongestant.
By Susan Morse | 04:35 pm | September 18, 2023
Rebates and fees received by PBMs account for 42% of every dollar spent on brand medicines in the commercial market, report says.
By Jeff Lagasse | 11:52 am | September 18, 2023
Improperly listing patents may harm competition from generic alternatives and keep prices artificially high, the FTC says.
By Susan Morse | 10:28 am | September 13, 2023
The vaccines from Pfizer-BioNTech and Moderna will be available later this week, CDC says.
By Susan Morse | 11:36 am | September 12, 2023
The number of hospitalizations and deaths in the United States continues to rise.
By Jeff Lagasse | 11:12 am | September 07, 2023
Walgreens is also making a $100,000 donation to End Overdose to support its efforts in educating the public on how to use the spray.
By Jeff Lagasse | 11:23 am | September 06, 2023
The QMM program aims to encourage drug manufacturers to implement quality management practices that go beyond current requirements.
By Susan Morse | 08:24 am | August 29, 2023
Negotiations with participating drug companies will occur in 2023 and 2024, and prices will become effective beginning in 2026. 
By Jeff Lagasse | 11:36 am | August 25, 2023
The products will be FDA approved, CVS says, adding the move should help ensure a more consistent supply of affordable biosimilars.
By Susan Morse | 11:04 am | August 24, 2023
Project NextGen funding includes $1B for clinical trials, $326M for a new monoclonal antibody and $100M for novel vaccines and therapeutics.